BioSpace News Archive

Biotech Beach

Arrowhead Receives Positive EMA Opinion on Orphan Designation for ARO-AAT for Treatment of Congenital Alpha-1 Antitrypsin Deficiency

ARO-AAT was previously granted orphan drug designation by the United States Food and Drug Administration in February 2018.

June 27, 2018
·
3 min read
Pharm Country

NucleoBio Concludes Preliminary Tests For New Drug to Treat Aggressive Prostate Cancer

Prostreat outperforms commercially available medications in inhibiting the growth and spread of the most aggressive form of prostate cancer: metastatic castration-resistant prostate cancer.

June 27, 2018
·
3 min read
BioMidwest

ANI Pharmaceuticals Announces Launch of Cholestyramine for Oral Suspension USP

The current annual U.S. market for this product is approximately $22 million, according to Iqvia/IMS Health.

June 27, 2018
·
3 min read
Business

Adicet Bio appoints Stewart Abbot, Ph.D. as Chief Scientific Officer

Dr. Abbot brings extensive industry experience in the research, early product development and clinical translation of cell-based therapies.

June 27, 2018
·
2 min read
Deals

CityMD Completes Acquisitions of STAT Health Urgent Care and First Med Immediate Medical Care

Terms of the transactions were not disclosed.

June 27, 2018
·
2 min read
Policy

DaVita Response to Legal Ruling

“We strongly disagree with this jury’s verdict and will vigorously pursue all appeal rights.”

June 27, 2018
·
4 min read
Business

Kent Imaging Inc. and SerenaGroup announce Strategic Partnership in wound care

Partnership to jointly improve tissue assessment in wounds with the use of Near Infrared Imaging technology using Kent’s KD203 device.

June 27, 2018
·
3 min read
BioMidwest

SKYGEN International Foundation Bringing Gift of Better Vision to Tanzania

Philanthropic organization partners with Essilor, Evangelical Lutheran Church of Tanzania and EyeNetra to deliver vision correction for up to 1,500 underserved Tanzanians

June 27, 2018
·
9 min read
Drug Development

Amgen Announces Top-Line Results From Phase 3 Study Of ABP 710, Biosimilar Candidate To Infliximab

Study Evaluated Efficacy and Safety of ABP 710 Compared With Infliximab in Patients With Moderate-to-Severe Rheumatoid Arthritis

June 27, 2018
·
10 min read
FDA

Beckman Coulter Diagnostics Receives U.S. FDA 510(k) Clearance for High- sensitivity Access hsTnI Assay

First high-sensitivity troponin I assay available in the United States enables clinicians to provide efficiency improvements in cardiac patient management

June 27, 2018
·
5 min read